Design and Optimization of Solid Lipid Nanoparticles Loaded with Triamcinolone Acetonide

Area of Science:

• Pharmaceutical Nanotechnology
• Drug Delivery Systems
• Materials Science

Background:

• Quality by Design (QbD) and Design of Experiments (DoE) are increasingly vital for developing novel drug carriers.
• Solid lipid nanoparticles (SLNs) are a promising class of drug delivery systems with versatile applications.
• Optimizing SLN synthesis is crucial for achieving desired physicochemical properties and therapeutic efficacy.

Purpose of the Study:

• To optimize the synthesis of Triamcinolone Acetonide-loaded solid lipid nanoparticles (SLNs).
• To investigate the impact of lipid and surfactant concentrations, and sonication amplitude on SLN characteristics.
• To achieve a formulation with maximized Zeta potential and minimized particle size for enhanced drug delivery.

Main Methods:

• Utilized a circumscribed Central Composite Design (CCD) approach for optimization.
• Employed Stearic Acid as the lipid, soy PC as the ionic surfactant, and Tween 80 as the nonionic surfactant.
• Characterized particle size and Zeta potential using Dynamic Light Scattering (DLS); determined encapsulation efficiency via Size Exclusion Chromatography (SEC) and HPLC-DAD.

Main Results:

• The optimized SLN formulation demonstrated excellent agreement with predicted values for particle size and Zeta potential.
• Achieved a particle dimension of 683 ± 5 nm (3% deviation from prediction) and a Zeta potential of -38.0 ± 7.6 mV (12% deviation).
• High encapsulation efficiency for Triamcinolone Acetonide was successfully obtained in the optimized SLN formulation.

Conclusions:

• The QbD-guided optimization successfully yielded an efficient Triamcinolone Acetonide-loaded SLN formulation.
• The optimized SLNs possess favorable physicochemical properties, including optimal particle size and Zeta potential.
• This study provides a robust methodology for the development of high-performance SLNs for drug delivery applications.